<DOC>
	<DOC>NCT00707551</DOC>
	<brief_summary>The purpose is to study whether ketoconazole or verapamil have an effect on how AZD1305 is handled by the body, i.e the absorption, distribution, metabolism and excretion, when administered in combination with AZD1305.</brief_summary>
	<brief_title>An Interaction Study of Ketoconazole/Verapamil Versus AZD1305</brief_title>
	<detailed_description />
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>A body mass index (BMI=weight/height2) of 19 to 30 kg/m2 Potassium outside normal reference values ECG findings outside normal range</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>AZD1305</keyword>
	<keyword>Verapamil</keyword>
	<keyword>Ketoconazole</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>